|
|
Volumn 50, Issue 5 SUPPL. 5, 1998, Pages
|
|
Catechol-O-methyltransferase inhibition with tolcapone reduces the 'wearing off' phenomenon and levodopa requirements in fluctuating parkinsonian patients
a
a
a
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
ASPARTATE AMINOTRANSFERASE;
BENSERAZIDE PLUS LEVODOPA;
CATECHOL METHYLTRANSFERASE;
CATECHOL METHYLTRANSFERASE INHIBITOR;
LEVODOPA;
TOLCAPONE;
ADULT;
AGED;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIARRHEA;
DISEASE SEVERITY;
DOUBLE BLIND PROCEDURE;
DRUG BIOAVAILABILITY;
DRUG EFFICACY;
DRUG HALF LIFE;
DYSKINESIA;
ENZYME INHIBITION;
FEMALE;
GASTROINTESTINAL SYMPTOM;
HALLUCINATION;
HUMAN;
HYPOTENSION;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
ORAL DRUG ADMINISTRATION;
PARKINSON DISEASE;
PRIORITY JOURNAL;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL;
RATING SCALE;
|
|
EID: 0031954352
PISSN: 00283878
EISSN: None
Source Type: Journal
DOI: 10.1212/wnl.50.5_suppl_5.s46 Document Type: Article |
|
Times cited : (33)
|
|
References (30)
|
